Patents by Inventor Gerald Ranges

Gerald Ranges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MN ANTIBODIES AND METHODS OF USING SAME
    Publication number: 20120301468
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods of using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 29, 2012
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Paul Tamburini, Gerald Ranges, Lila Adnane, Timothy McCabe, Pamela Trail, Sha Ha
  • Anti-MN antibodies and methods of using same
    Patent number: 8168758
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods for using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: May 1, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Paul Tamburini, Gerald Ranges, Lila Adnane, Timothy Mccabe, Pamela Trail, Sha Ha
  • INHIBITION OF P38 KINASE ACTIVITY BY ARYL UREAS
    Publication number: 20100160371
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: November 17, 2009
    Publication date: June 24, 2010
    Inventors: Gerald RANGES, William Scott, Michael Bombara, Deborah Rauner, Aniko Redman, Roger Smith, Holger Paulsen, David Gunn, Jinshan Chen, Joel Renick
  • Anti-MN Antibodies and Methods of Using Same
    Publication number: 20100129315
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods for using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Application
    Filed: December 12, 2006
    Publication date: May 27, 2010
    Applicant: Bayer Healthcare LLC
    Inventors: Paul Tamburini, Gerald Ranges Hamden, Lila Adnane, Timothy McCabe, Pamela Trail, Sha Ha
  • Inhibition of p38 kinase activity by aryl ureas
    Publication number: 20020103253
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: September 7, 2001
    Publication date: August 1, 2002
    Applicant: BAYER CORPORATION
    Inventors: Gerald Ranges, William Scott, Michael Bombara, Deborah Rauner, Aniko Redman, Roger Smith, Holger Paulsen, David Gunn, Jinshan Chen, Joel Renick
  • Inhibition of p38 kinase activity by aryl ureas
    Patent number: 6344476
    Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: February 5, 2002
    Assignee: Bayer Corporation
    Inventors: Gerald Ranges, William Scott, Michael Bombara, Deborah Rauner, Aniko Redman, Roger Smith, Holger Paulsen, David Gunn, Jinshan Chen, Joel Renick